Introduction: Inflammatory conditions modulated by Chlamydophila (Chlamydia) pneumoniae are considered to play an important role in the onset of atherosclerosis. In this paper we present the results of progressive observation of C. pneumoniae antibody titres in patients who underwent coronary artery bypass graft (CABG). Material and methods: The objective of our research was a prospective observation of antibody titres in IgA and IgG class antibodies against C. pneumoniae using indirect immunofluorescence in a group of 155 post-surgery CABG patients suffering from heart ischaemia. The microbiological test results were compared with patients' present coronary complaints evaluated on the CCS scale during a six-year period. Results: Six years after CABG, 128 patients (82.6%) are still alive. During the study a positive serological conversion of antibody titres was observed in 36 patients in the IgA class antibodies, and in 26 patients in the IgG class. The group of patients with no antibodies against C. pneumoniae decreased from 23.2 to 3.4%, while the group of patients with antibodies in both IgG and IgA classes increased from 52.3 to 83.9%. The average CCS degree decreased from 3.18 before CABG to 1.65 in the present study. Conclusions: These results show no connection between the serological symptoms of chronic C. pneumoniae infection and coronary complaints evaluated on the CCS scale during a six-year study on post-CABG patients suffering from heart ischaemia. The surgical treatment of heart ischaemia brought about longterm improvement in the coronary condition of the observed group of patients.
Introduction
Damage of the endothelium is considered to be crucial in the onset of atherosclerosis. It leads to increase in T lymphocyte adhesion, release of numerous cytokines, and then to proliferation of smooth muscle. As a result of the process atherogenesis, atheromatosus plaque are formed. They cause limitation of the coronary reserve, which manifests as patients' coronary complaints. In addition to well-known, classical risk factors which Table I . Classification of antibody titres against C. pneumoniae can initiate the atherogenesis, some bacterial and viral infections are also considered to play a role in the aetiology of CAD. Chlamydophila pneumoniae (C. pneu moniae), responsible for atypical bronchitis and pneumonia, is in the range of interest of some researchers. A chronic C. pneumoniae infection shows a modulating influence on the development of atherosclerosis, thus increasing the level of independent risk factors for coronary disease, such as acute phase protein or LDL cholesterols [1] [2] [3] [4] . Saikku et al. [5] were the first to notice the appearance of antibodies against C. pneumoniae in patients suffering from coronary artery disease and myocardial infarction. Thom et al. [6] in their paper showed that an elevated level of antibodies against C. pneumoniae increases the probability of development of coronary artery disease almost three times. A common method of diagnosing C. pneumoniae-triggered-inflammations is to examine patient's serum for species-specific IgM, IgG and IgA class antibodies. Determining the dynamics of appearance and disappearance of particular immunoglobulin classes allows one to diagnose what kind of infections the patient suffers from: primary, chronic, or reinfection. In an acute primary infection, IgM class antibodies appear first and their levels remain increased for about 2 months, to gradually subside later. Next, the IgG class antibody titre levels increase, and then the same elevation is noticed in the IgA class. In case of successful treatment and no reinfection, the antibody levels slowly decrease, despite the fact that elevation in IgG class antibody levels is usually observed proportionally to the patient's age. Increased, but remaining stable, the level of IgG class antibodies, and, in particular, IgA class antibodies may indicate a chronic infection and/or frequently reoccurring infections [7] .
The objective of this study was to compare the C. pneumoniae antibody levels in 118 patients treated surgically for coronary artery disease preoperatively and after six years of follow-up. In this study we also tried to evaluate the influence of C. pneumoniae infection on the late results of surgical treatment of CAD. (Table I) . For the purpose of statistical analysis and avoidance of division into smaller groups, each titre value of antibodies was assigned a specific score. Depending on the dilution of solution in which the antibodies were detected, their corresponding titres were assigned a point score (Table II) . Adding the scores for detecting antibodies in particular IgA and IgG antibody titres, we received qualification which allowed for a statistical analysis of the degree of C. pneumoniae infection in patients (Table III) .
Material and methods
The data were completed for all 155 patients in the 2000 Study. 128 patients (82.5%) were still alive, 27 patients (17.4%) died, and 10 living patients (6.45%) did not consent to participate in the control study.
Both studies were financed by the State Committee for Scientific Research from the Science and Research Fund: KBN 4P05C05815 and KBN 2P05C03529. Both studies were accepted by the Ethics Committee of the Pomeranian Medical University. Data were analysed using STATISTICA 6.0 software.
Results
The results of serological tests done preoperatively in 155 patients in the 2000 Study showed specific antibodies against C. pneumoniae in IgG class in 110 patients (71%), and in IgA class in 90 patients (58,1%). In 81 patients (52.3%) antibodies in both IgA class (1 : 50 or 1 : 100 solutions) and IgG class (1 : 100 and 1 : 1000 solutions) were found. In 36 surgery patients (23.22%) no antibodies in either of those classes were found.
Another titre assay and a comparative analysis with the previous results was conducted on 118 patients (Table IV between 9 and 76 months following the surgery (the mean number of months following the surgery was 51). The most frequent cause of death was coronary condition. Obtaining reliable medical documentation for some of the deceased was not always possible. In two cases (7.4%) the direct cause of death was cancer, and in another two (7.4%) cerebral stroke. The most deaths, i.e. 16 (24.2%), occurred in those patients who in the 2000 Study had no antibodies or low-titre antibodies in one class only (0-1 points) (p < 0.05 -sign test). However, all three post-surgery deaths (0-30 days) occurred in this group. But they were caused by cardiac insufficiency, and not by a chronic infection. Respectively, in the increased titre group 7 deaths (10.8%) occurred, and 4 deaths (16.7%) in the high titre group (Table II) . These correlations, however, were not statistically significant in our research.
Discussion
It has been over ten years since the first papers on the coexistence of C. pneumoniae chronic infection symptoms and atherosclerotic disease were published. There exist over 800 publications on the subject, but none offers a definite answer as to what function and impact this infection has in the atherosclerotic disease pathogenesis. Although, as of today, there is no incontrovertible evidence which would clearly indicate a direct connection between the onset of arthrosclerosis and C. pneumoniae inflammation, many researchers are inclined to agree with the theory that a chronic bacterial inflammation modulates the process of atherogenesis. Strachan et al. [10] published data indicating a relationship between C. pneumoniae infection and a higher mortality rate in coronary artery disease for persons with an elevated level of IgA class antibodies. Similarly, Lindholt et al. [11] in their research showed elevated titres in IgA class antibodies in abdominal aortic aneurysm patients. Anzini et al. [12] researched the influence of C. pneumoniae infection on ischaemic stroke in young patients (aged 18-46 years) and concluded that the elevated titre in IgA class antibodies was significantly higher than in the control group. Zairis et al. [13] found a relationship between chronic C. pneumoniae infection and progression of Table VIII . Improvement by 1, 2, 3 CCS classes, no change or exacerbation (0) within 6 years after CABG in the investigated groups in both studies The death of a patient during follow-up seems to be a victory of the disease over the applied treatment plan. The highest, statistically significant mortality occurred in the group of patients who either had no antibodies against C. pneumoniae or whose titres in one of the groups was low. To some extent, the fact could be blamed on their mean age, which was 2.4 years higher than in the group of surviving patients. The observations we made seem to accord with the research results published by Martinez et al. [14] . They reported that an increase in titres of antibodies against C. pneumoniae positively correlated with increasing mean age of the study group. Particularly important is that, in our research, we combined long-term observation of post-CABG patients with observation of the occurrence of positive conversion of the titres of antibodies against C. pneumoniae. In the group with a high antibody titre we did not find a significant negative serum conversion, which may indicate a reinfection and/or a chronic inflammatory process caused by C. pneumoniae. The number of patients who had symptoms of C. pneumoniae infection was significantly higher between the ages of 50 and 75 than in other such studies [14] [15] [16] . The analysis of the population of patients suffering from coronary artery disease indicates a higher number of C. pneumoniae infections and a greater extent of its development than in a population not affected by heart ischaemia. Evaluation of the degree of coronary complaints in postoperative patients assessed on the CCS scale showed a significant improvement in all the groups. In patients with especially intensified coronary complaints before CABG the reoccurrence of coronary complaints after CABG depends on both degeneration processes in the grafts and the development of alterations in the patients' own blood vessels. Our study does not confirm the observations of other scientists who describe a parallel increase in the coronary complaints along with the increasing frequency of high titres of antibodies against C. pneumoniae. On the contrary, the group with the highest titre of antibodies against C. pneumoniae from the 2006 Study reported the least reoccurrence of coronary complaints. Our observations are contrary to those of Gurfinkel et al. [17] , which suggested that an increase in the titres of antibodies against C. pneumoniae is related to the intensification of coronary complaints and is observed more frequently in patients suffering from acute coronary syndrome. Frequent acute infections of patients' upper and lower respiratory tract during the observation period indicate a greater probability of becoming infected by this common bacterium. It was noted that respiratory tract infections as well as antibiotic treatment were more frequent in the group with the highest antibody titre than in the remaining groups. As a result of antibiotic treatment, the inflammatory process in the endothelium may become temporarily suppressed, regardless of the factors which cause that condition. It appears that the role CP infection plays in progression of atherosclerotic disease is not as significant as the role other coexisting risk factors might play, particularly in cases where an intensive multimodal treatment is applied. In conclusion: 1) the results of the research indicate a lack of association between a chronic C. pneumoniae infection and intensification of coronary complaints evaluated on the CCS scale in patients with CAD treated surgically during a sixyear observation period; 2) microbiological test results indicate increasing frequency of the occurrence of high titres of antibodies against C. pneumoniae during the follow-up after surgical treatment of CAD; 3) surgical treatment of coronary artery disease brought long-term relief in coronary complaints.
